The association of estimated whole blood viscosity with hemodynamic parameters and prognosis in patients with heart failure.


Journal

Biomarkers in medicine
ISSN: 1752-0371
Titre abrégé: Biomark Med
Pays: England
ID NLM: 101312535

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 24 1 2019
medline: 7 1 2020
entrez: 24 1 2019
Statut: ppublish

Résumé

We aimed to investigate the association of estimated whole blood viscosity (WBV) with hemodynamic parameters and prognosis in patients with heart failure with reduced ejection fraction. Total of 542 patients were included and followed-up for median 13 months. The WBV parameters had negative relationship with right atrium pressure and positive correlation with cardiac index. The WBV parameters were found to be independent predictors of composite end point (CEP) and all-cause mortality. Every one cP increases of WBV(h) and WBV(l) were associated with 17 and 1% reductions of CEP. In Kaplan-Meier analysis, patients with low WBV quartiles were found to have significantly more CEP. Being an easily accessible and costless prognosticator, WBV seems to be a novel marker for determining prognosis and an emerging tool to individualize heart failure with reduced ejection fraction management.

Identifiants

pubmed: 30672319
doi: 10.2217/bmm-2018-0309
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-82

Auteurs

Elif Hande Ozcan Cetin (EH)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Mehmet Serkan Cetin (MS)

Faculty of Medicine, Cardiology, TOBB-ETU University, Ankara, Turkey.

Kumral Çağlı (K)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Ahmet Temizhan (A)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Mustafa Bilal Özbay (MB)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Emek Ediboglu (E)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Özlem Özcan Çelebi (Ö)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Dursun Aras (D)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Serkan Topaloglu (S)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Sinan Aydogdu (S)

Cardiology Department, Turkey Yuksek Ihtisas Training & Research Hospital, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH